These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 35027028)
1. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028 [TBL] [Abstract][Full Text] [Related]
2. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity. Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001 [TBL] [Abstract][Full Text] [Related]
3. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis. Xie S; Li S; Chen B; Zhu Q; Xu L; Li F Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672 [TBL] [Abstract][Full Text] [Related]
4. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases. Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478 [TBL] [Abstract][Full Text] [Related]
5. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis. Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G Front Immunol; 2018; 9():876. PubMed ID: 29740454 [TBL] [Abstract][Full Text] [Related]
6. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Castellanos-Moreira R; Rodríguez-García SC; Gomara MJ; Ruiz-Esquide V; Cuervo A; Casafont-Solé I; Ramírez J; Holgado S; Gómez-Puerta JA; Cañete JD; Haro I; Sanmarti R Ann Rheum Dis; 2020 May; 79(5):587-594. PubMed ID: 32156708 [TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis-associated antibodies in healthy first-degree relatives of RA patients. Vega-Morales D; Pérez-Barbosa L; Vega-Sevilla LF; Esquivel-Valerio JA; Ramírez-Monterrubio LE; Gonzalez-Torres KI; Leal-Bramasco AS; Elizondo-Solis CV; Mendiola-Jimenez A; Garza-Elizondo MA; Galarza-Delgado DÁ Int J Immunogenet; 2023 Feb; 50(1):19-23. PubMed ID: 36428093 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients. Meyer P; Ally M; Hodkinson B; Anderson R; Tikly M Afr Health Sci; 2018 Jun; 18(2):295-303. PubMed ID: 30602956 [TBL] [Abstract][Full Text] [Related]
9. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639 [TBL] [Abstract][Full Text] [Related]
11. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484 [TBL] [Abstract][Full Text] [Related]
12. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis. Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962 [TBL] [Abstract][Full Text] [Related]
13. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Shi J; Knevel R; Suwannalai P; van der Linden MP; Janssen GM; van Veelen PA; Levarht NE; van der Helm-van Mil AH; Cerami A; Huizinga TW; Toes RE; Trouw LA Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17372-7. PubMed ID: 21987802 [TBL] [Abstract][Full Text] [Related]
14. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans. Natalini JG; Baker JF; Singh N; Mahajan TD; Roul P; Thiele GM; Sauer BC; Johnson CR; Kawut SM; Mikuls TR; England BR Ann Am Thorac Soc; 2021 Apr; 18(4):598-605. PubMed ID: 33026891 [No Abstract] [Full Text] [Related]
15. [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease]. Zhu H; Zhao LJ; Zhou Y; Chen Y Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1003-1007. PubMed ID: 31848494 [TBL] [Abstract][Full Text] [Related]
16. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis. Dibrov DA; Avdeeva AS; Diatroptov ME; Nasonov EL Dokl Biochem Biophys; 2024 Aug; 517(1):235-242. PubMed ID: 39002007 [TBL] [Abstract][Full Text] [Related]
17. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients. van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902 [TBL] [Abstract][Full Text] [Related]
18. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example. Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies. Reed E; Jiang X; Kharlamova N; Ytterberg AJ; Catrina AI; Israelsson L; Mathsson-Alm L; Hansson M; Alfredsson L; Rönnelid J; Lundberg K Arthritis Res Ther; 2016 May; 18(1):96. PubMed ID: 27145822 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical characteristics of symptomatic diffuse interstitial lung disease in rheumatoid arthritis in a Spanish population. Bonilla Hernán MG; Gómez-Carrera L; Fernández-Velilla Peña M; Álvarez-Sala Walther R; Balsa A Rev Clin Esp (Barc); 2022 May; 222(5):281-287. PubMed ID: 34583914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]